|
Pharmacological targeting of BET proteins inhibits renal fibroblast activation
|
7
|
Resverlogix Corp.
|
Oct 27, 2016 04:47PM
|
|
New patent application (filed January 18, 2017; published May 4, 2017)
|
7
|
Resverlogix Corp.
|
May 08, 2017 11:32AM
|
|
Re: Back to the FDA
|
7
|
Resverlogix Corp.
|
Oct 04, 2019 11:37AM
|
|
Re: 25% Pop in SP .... Now $1.12
|
7
|
Resverlogix Corp.
|
Mar 15, 2021 10:46AM
|
|
New patent (January)
|
7
|
Resverlogix Corp.
|
Feb 24, 2016 06:07PM
|
|
Re: Beating the dead horse
|
7
|
Resverlogix Corp.
|
Nov 12, 2017 01:49PM
|
|
Re: Microcap bought in CVR deal - stock is up 700%
|
7
|
Resverlogix Corp.
|
Sep 20, 2016 04:59PM
|
|
Re: HL
|
7
|
Resverlogix Corp.
|
Nov 17, 2017 03:55PM
|
|
Re: Peer Reviewed.....A question for the board
|
7
|
Resverlogix Corp.
|
Jan 24, 2016 05:26AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
6
|
Resverlogix Corp.
|
May 26, 2017 08:37AM
|
|
Re: ... a couple things...
|
6
|
Resverlogix Corp.
|
May 09, 2018 05:48PM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
6
|
Resverlogix Corp.
|
May 26, 2017 09:18AM
|
|
Re: RVX rises above 200-day moving average
|
6
|
Resverlogix Corp.
|
Sep 21, 2020 03:26PM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
6
|
Resverlogix Corp.
|
Jun 22, 2017 02:12PM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
6
|
Resverlogix Corp.
|
Oct 07, 2016 11:05AM
|
|
Re: 50% Discount to China deal ...
|
6
|
Resverlogix Corp.
|
Mar 22, 2016 11:29AM
|
|
Re: New Frontiers for both RVX/Zenith
|
6
|
Resverlogix Corp.
|
Apr 18, 2017 03:56PM
|
|
New article on Apabetalone
|
6
|
Resverlogix Corp.
|
Oct 16, 2017 10:30AM
|
|
From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
6
|
Resverlogix Corp.
|
Oct 21, 2020 01:59PM
|
|
Question for the board
|
6
|
Resverlogix Corp.
|
Feb 16, 2016 09:38AM
|
